Published Dec 6, 2023
Jeff Galvin, CEO of Addimmune on Finding a Cure for HIV
Jeff Galvin, CEO of Addimmune, reveals his transition from Silicon Valley to revolutionizing HIV treatment with the groundbreaking gene therapy AGT 103, sharing insights into the potential of gene therapy to transform pharmaceuticals and offer a cure for HIV.
